 Benitec BioPharma Inc. NASDAQ: BNTC shares rallied Tuesday following a filing by Morgan Stanley that showed the bank increased its stake in the Australian biotechnology company by 5.2. The stock gained 190.28 in Tuesdays session, closing at 9.26, and was giving back 11.12 to 8.23 in after-hours trading at last check. 